Belmont Research signs OEM agreement with Pharsight.CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 21, 1996-- Belmont's CrossGraphs for advanced data visualization Using the computer to convert data into picture form. The most basic visualization is that of turning transaction data and summary information into charts and graphs. Visualization is used in computer-aided design (CAD) to render screen images into 3D models that can be viewed from all to create graphical reports for Pharsight simulation software Simulation software is based on the process of imitating a real phenomenon with a set of mathematical formulas. It is, essentially, a program that allows the user to observe an operation through simulation without actually running the program. Belmont Research Inc., a leading developer of advanced data visualization See information visualization. tools, announced that it has formed a new partnership with Pharsight Corp., which develops simulation software for use by pharmaceutical, research and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. in clinical drug development. Under the terms of the multi-year agreement, Belmont's CrossGraphs will be integrated into the Pharsight product suite and shipped with Pharsight simulation software. "Pharsight is breaking new ground as it utilizes simulation technology to help pharmaceutical companies speed the clinical drug development process, and we're delighted to be making a contribution to their work," comments Paul Castleman, chairman of Belmont Research. "CrossGraphs' ability to present data in arrays of graphs, revealing important trends and relationships is a powerful and synergistic synergistic /syn·er·gis·tic/ (sin?er-jis´tik) 1. acting together. 2. enhancing the effect of another force or agent. syn·er·gis·tic adj. 1. technology with Pharsight simulation software," continues Castleman. As a complementary data analysis tool, CrossGraphs will enable Pharsight users to graphically view simulated data gathered during the planning phases In amphibious operations, the phase normally denoted by the period extending from the issuance of the order initiating the amphibious operation up to the embarkation phase. The planning phase may occur during movement or at any other time upon receipt of a new mission or change in the of the clinical drug development process. Pharsight and CrossGraphs Research indicates that more than half of all clinical trials fail. With Pharsight software, clinical project directors, pharmacometricians and biostatisticians can make informed decisions about the expected outcome of clinical trials before trials begin. This advance knowledge enables these pharmaceutical professionals to fine-tune design parameters and target their drug development efforts to areas where success is most likely. Using the Pharsight simulation system injects a level of scientific probability analysis into the drug development process that has been previously unavailable. As a result, pharmaceutical companies are expected to reduce drug development costs and time to market. With CrossGraphs, Pharsight users can visually interpret large quantities of clinical trials simulation data quickly and intuitively. "By linking Pharsight simulation software to CrossGraphs, users can view data in both standard statistical presentations and intuitive visual graphs. Adding a visual format to data representation enables drug development professionals to refine clinical development plans for maximum efficiency, and to communicate study objectives and results across the entire development team," says Arthur Reidel, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Pharsight. "Our alliance with Belmont teams us with a premier provider of visualization software, strengthening our commitment to helping organizations accelerate clinical development. We believe this capability will lead to competitive advantage and more successful drug marketing programs," continues Reidel. Availability Pharsight with CrossGraphs will be shipping directly from Pharsight in Q1 of 1997. The product set runs on industry-leading platforms including, personal computers with Windows 3.1, Windows for Workgroups A version of Windows 3.1 introduced in 1992 that added peer-to-peer networking. See Windows. (operating system) Windows for Workgroups - (WFW, WFWG) A version of Windows 3.1 which works with a network. Although stand-alone 3. 3.11, Windows95 and Windows NT (Windows New Technology) A 32-bit operating system from Microsoft for Intel x86 CPUs. NT is the core technology in Windows 2000 and Windows XP (see Windows). Available in separate client and server versions, it includes built-in networking and preemptive multitasking. . CrossGraphs is shipping directly from Belmont Research. In North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , pricing starts at $795.00 for all Windows platforms; and $1,595 per user for systems running on SunOS, Solaris, and HP-UX HP's version of Unix that runs on its 9000 family. It is based on SVID and incorporates features from BSD Unix along with several HP innovations. (operating system) HP-UX - The version of Unix running on Hewlett-Packard workstations. . The Customization Option is priced at $1,995 per programmer on Windows, and $3,995 on SunOS, Solaris, and HP-UX. Belmont Research Inc. Belmont Research develops, markets and supports data visualization, data management, and rapid application development software for organizations that require innovative solutions for retrieving, understanding, managing and reporting complex data. Belmont's technologies help companies improve the cost and quality of products, quickly bring those products to markets, and compete effectively. The company's worldwide customer base includes leading engineering, scientific and business organizations involved in information-intensive industries such as, pharmaceuticals, biotechnology, government, and microelectronics. Founded in 1990, the company has offices in Cambridge (Massachusetts), San Mateo San Mateo (săn mətā`ō), city (1990 pop. 85,486), San Mateo co., W Calif., on San Francisco Bay; inc. 1894. It is a commercial and retail center with some high-technology manufacturing. San Mateo, Spanish for St. (California) and Brussels (Belgium). Belmont Research is headquartered at 84 Sherman St., Cambridge, Mass., 02140. Tel: 617/868-6878; Fax: 617/868-2654; Email: cginfo@belmont.com; Web Site: http://www.belmont.com. Pharsight Corporation Pharsight Corp. provides software products and services used by clinical project directors, pharmacometricians and biostatisticians in the pharmaceutical and biotechnology industries. Pharsight software allows clinical development professionals to simulate clinical trials and refine test parameters throughout the clinical trials process. These planning tools for the human clinical phases of drug development are expected to increase the probability of a successful, informative and efficient clinical trial. Founded in 1995, the company is headquartered at 299 California Ave., Suite 300, Palo Alto Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. 94306. Tel: 415/462-5600; Fax: 415/462-5610; Email: info@pharsight.com; Web Site: http://www.pharsight.com. -0- CrossGraphs is a trademark of Belmont Research Inc. Pharsight is a trademark of Pharsight Corp. Other product and company names mentioned herein may be trademarks or registered trademarks of their respective companies. CONTACT: Public Relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most for Belmont Research Jacquelyn Thrasivoulos, 508/881-3109 jthrasi@aol.com or Public Relations for Pharsight Jim Owen, 415/512-0770 jowens@schwartz.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion